Cookies help us to understand how you use our website so that we can provide you with the best experience when you are on our site. To find out more, read our privacy policy and cookie policy.
Manage Cookies
A cookie is information stored on your computer by a website you visit. Cookies often store your settings for a website, such as your preferred language or location. This allows the site to present you with information customized to fit your needs. As per the GDPR law, companies need to get your explicit approval to collect your data. Some of these cookies are ‘strictly necessary’ to provide the basic functions of the website and can not be turned off, while others if present, have the option of being turned off. Learn more about our Privacy and Cookie policies. These can be managed also from our cookie policy page.
Strictly necessary cookies(always on):
Necessary for enabling core functionality. The website cannot function properly without these cookies. This cannot be turned off. e.g. Sign in, Language
Analytics cookies:
Analytical cookies help us to analyse user behaviour, mainly to see if the users are able to find and act on things that they are looking for. They allow us to recognise and count the number of visitors and to see how visitors move around our website when they are using it. Tools used: Google Analytics
Social media cookies:
We use social media cookies from Facebook, Twitter and Google to run Widgets, Embed Videos, Posts, Comments and to fetch profile information.
Could you help us develop research for head and neck cancer?
Share Could you help us develop research for head and neck cancer? on FacebookShare Could you help us develop research for head and neck cancer? on TwitterShare Could you help us develop research for head and neck cancer? on LinkedinEmail Could you help us develop research for head and neck cancer? link
Consultation has concluded
We would like to talk to people with experience of head and neck cancer – either as a patient, family/friend, or carer. Your thoughts and opinions are invaluable and will help us develop a new head and neck cancer research trial, called immunoREACH.
One of the most important questions for people who have been through radiotherapy is ‘how do we know if the cancer is going to come back’? We are trying to find more accurate and effective ways of detecting when cancer has come back through research. ImmunoREACH aims to test if a simple blood test, or ‘liquid biopsy’, can detect the return of cancer earlier than usual imaging (i.e., CT scan). This could improve outcomes by giving more patients the option of surgery and the potential for earlier treatment with immunotherapy.
We would like to know how you feel about this research to make sure the reasons why we want to run this trial are easy to understand, and that we are asking the best research questions for patients. Communicating the research background, along with the possible risks and benefits in a clear and understandable way, is essential to ensure that immunoREACH is designed so that everyone, including underserved groups, has the opportunity to take part.
We are particularly keen to hear from those who find it difficult to travel for treatment, have caring/work responsibilities and welcome those from different backgrounds and cultures.
Planned online Discussion Groups will be held on:
Thursday 29th February: 16:00 – 17:00
Tuesday 5th March: 14:00 – 15:00
Wednesday 6th March: 19:00 – 20:00
Groups will be up to 60 mins long and participants will receive a one off payment of £30. If you would like to attend one of these discussion groups, please email [email protected] by 27th February 2024.
We would like to talk to people with experience of head and neck cancer – either as a patient, family/friend, or carer. Your thoughts and opinions are invaluable and will help us develop a new head and neck cancer research trial, called immunoREACH.
One of the most important questions for people who have been through radiotherapy is ‘how do we know if the cancer is going to come back’? We are trying to find more accurate and effective ways of detecting when cancer has come back through research. ImmunoREACH aims to test if a simple blood test, or ‘liquid biopsy’, can detect the return of cancer earlier than usual imaging (i.e., CT scan). This could improve outcomes by giving more patients the option of surgery and the potential for earlier treatment with immunotherapy.
We would like to know how you feel about this research to make sure the reasons why we want to run this trial are easy to understand, and that we are asking the best research questions for patients. Communicating the research background, along with the possible risks and benefits in a clear and understandable way, is essential to ensure that immunoREACH is designed so that everyone, including underserved groups, has the opportunity to take part.
We are particularly keen to hear from those who find it difficult to travel for treatment, have caring/work responsibilities and welcome those from different backgrounds and cultures.
Planned online Discussion Groups will be held on:
Thursday 29th February: 16:00 – 17:00
Tuesday 5th March: 14:00 – 15:00
Wednesday 6th March: 19:00 – 20:00
Groups will be up to 60 mins long and participants will receive a one off payment of £30. If you would like to attend one of these discussion groups, please email [email protected] by 27th February 2024.
